1. Home
  2. CCHH vs SNGX Comparison

CCHH vs SNGX Comparison

Compare CCHH & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCHH

CCH Holdings Ltd Ordinary Shares

N/A

Current Price

$0.66

Market Cap

10.2M

Sector

N/A

ML Signal

N/A

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.15

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCHH
SNGX
Founded
2015
1987
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2M
11.2M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
CCHH
SNGX
Price
$0.66
$1.15
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
1.2M
164.7K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.03
EPS
N/A
N/A
Revenue
N/A
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$43.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$1.00
52 Week High
$15.39
$6.23

Technical Indicators

Market Signals
Indicator
CCHH
SNGX
Relative Strength Index (RSI) 47.55 44.92
Support Level $0.62 $1.01
Resistance Level $0.68 $1.47
Average True Range (ATR) 0.06 0.09
MACD 0.01 -0.01
Stochastic Oscillator 26.55 45.31

Price Performance

Historical Comparison
CCHH
SNGX

About CCHH CCH Holdings Ltd Ordinary Shares

CCH Holdings Ltd operates a hotpot restaurant chain in Malaysia, specializing in chicken hotpot and fish head hotpot, mainly under two brand, namely Chicken Claypot House and Zi Wei Yuan, owned by the wholly owned subsidiaries of the Company. The Company conducts its operations through its wholly owned subsidiaries in Malaysia and is engaged as a restaurant operator, licensor and loyalty owner, and general trader. Currently, the Group has developed a restaurant chain including approximately 15 company-owned restaurant outlets, 13 franchised restaurant outlets in Malaysia, and 4 franchised restaurant outlets outside Malaysia.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: